Who owns Talis Biomedical Corporation?
- Ticker: TLIS
- CUSIP Number: 87424l207
Tip: Access positions for across all investors
Analyze quarterly positions in Talis Biomedical Corporation with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Talis Biomedical Corporation stock
Who bought or sold Talis Biomedical Corporation this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Baker Bros. Advisors | 508k | $3.8M | 0% | Dec 2023 |
|
| Greenlight Capital | 149k | $1.1M | 0% | Dec 2023 |
|
| BML Capital Management | 43k | $318k | 100% | Dec 2023 |
|
| Vanguard Group | 31k | $231k | 1% | Dec 2023 |
|
| Citadel Advisors | 10k | $75k | 100% | Dec 2023 |
|
| Citigroup | 1.6k | $12k | -69% | Dec 2023 |
|
| UBS Group | 127.00 | $952.500000 | 40% | Dec 2023 |
|
| Advisor Group Holdings | 105.00 | $782.019000 | -39% | Dec 2023 |
|
| Larson Financial Group | 14.00 | $104.000400 | 0% | Dec 2023 |
|
| Wells Fargo & Company | 13.00 | $96.999500 | 8% | Dec 2023 |
|
| Jpmorgan Chase & Co | 2.00 | $15.000000 | 100% | Dec 2023 |
|
Who sold out of Talis Biomedical Corporation?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Deutsche Bank Aktiengesellschaft | Sep 2023 | 600.00 | $3.5k |
| Royal Bank of Canada | Sep 2023 | 281.00 | $2.0k |